• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催化性DNA拓扑异构酶II抑制剂右丙亚胺(ICRF - 187)可诱导中国仓鼠卵巢细胞产生内多倍体。

The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells.

作者信息

Hasinoff B B, Abram M E, Chee G L, Huebner E, Byard E H, Barnabé N, Ferrans V J, Yu Z X, Yalowich J C

机构信息

Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

J Pharmacol Exp Ther. 2000 Nov;295(2):474-83.

PMID:11046078
Abstract

The bisdioxopiperazines, including dexrazoxane (ICRF-187), are catalytic or noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce DNA strand breaks. In this study we show that dexrazoxane inhibits the division of Chinese hamster ovary (CHO) cells resulting in marked increases in cell size (up to 80 microm in diameter), volume (up to 150-fold greater), and ploidy (as high as 32N). This last result indicates that the dexrazoxane-induced DNA reduplication was restricted to once per cell cycle. Kinetic analysis of the flow cytometry data indicated that the conversion between successively higher ploidy levels was progressively slowed at longer times of exposure to dexrazoxane. Both the protein and DNA content of dexrazoxane-treated CHO cells increased linearly over time in the same proportion. Light and electron microscopic studies of dexrazoxane-treated cells showed ring-like multilobulated nuclei. Immunohistochemical staining of dexrazoxane-treated cells showed that F-actin and acetylated alpha-tubulin were present in large, highly organized networks. Immunohistochemical staining of the dexrazoxane-treated CHO cells also showed that the topoisomerase II alpha colocalized with the DNA of the multilobulated nuclei. Staining of gamma-tubulin revealed that the dexrazoxane-treated cells contained multiple centrosomes, indicating that dexrazoxane prevents cytokinesis but not centrosome reduplication. It is concluded that dexrazoxane inhibits CHO cytokinesis in cells by virtue of its ability to inhibit topoisomerase II.

摘要

双二氧哌嗪类化合物,包括右丙亚胺(ICRF - 187),是DNA拓扑异构酶II的催化性或不可裂解的复合物形成抑制剂,不会导致DNA链断裂。在本研究中,我们表明右丙亚胺抑制中国仓鼠卵巢(CHO)细胞的分裂,导致细胞大小显著增加(直径可达80微米)、体积(高达150倍)和倍性(高达32N)。最后这一结果表明,右丙亚胺诱导的DNA复制在每个细胞周期中仅发生一次。流式细胞术数据的动力学分析表明,在较长时间暴露于右丙亚胺的情况下,连续更高倍性水平之间的转换逐渐减慢。右丙亚胺处理的CHO细胞的蛋白质和DNA含量随时间呈线性增加,比例相同。对右丙亚胺处理的细胞进行光镜和电镜研究显示有环状多叶核。对右丙亚胺处理的细胞进行免疫组织化学染色显示,F - 肌动蛋白和乙酰化α - 微管蛋白存在于大型、高度有序的网络中。对右丙亚胺处理的CHO细胞进行免疫组织化学染色还显示,拓扑异构酶IIα与多叶核的DNA共定位。γ - 微管蛋白染色显示,右丙亚胺处理的细胞含有多个中心体,表明右丙亚胺阻止胞质分裂但不阻止中心体复制。结论是右丙亚胺凭借其抑制拓扑异构酶II的能力抑制CHO细胞的胞质分裂。

相似文献

1
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells.催化性DNA拓扑异构酶II抑制剂右丙亚胺(ICRF - 187)可诱导中国仓鼠卵巢细胞产生内多倍体。
J Pharmacol Exp Ther. 2000 Nov;295(2):474-83.
2
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.对拓扑异构酶II催化抑制剂ICRF-159具有抗性的中国仓鼠卵巢细胞:Tyr49Phe突变赋予对双二氧哌嗪的高水平抗性。
Cancer Res. 1998 Apr 1;58(7):1460-8.
3
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.拓扑异构酶II导向的双二氧哌嗪抗癌药物ICRF-187(右丙亚胺)在酵母和哺乳动物细胞中诱导的细胞毒性和DNA损伤的表征
BMC Pharmacol. 2004 Dec 2;4:31. doi: 10.1186/1471-2210-4-31.
4
Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl(2)(dexrazoxane) and cis-PtCl(2)(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186).
J Inorg Biochem. 2004 Apr;98(4):616-24. doi: 10.1016/j.jinorgbio.2004.01.008.
5
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.一种对拓扑异构酶II的双二氧代哌嗪类催化抑制剂右丙亚胺(ICRF-187)产生获得性抗性的中国仓鼠卵巢细胞系的特性研究
Biochem Pharmacol. 1997 Jun 15;53(12):1843-53. doi: 10.1016/s0006-2952(97)00013-0.
6
Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.参与将DNA切割成拓扑结构域的拓扑异构酶II活性在一种多药耐药的中国仓鼠卵巢细胞系中发生了改变。
Mol Pharmacol. 1993 Feb;43(2):207-16.
7
The one-ring open hydrolysis intermediates of the cardioprotective agent dexrazoxane (ICRF-187) do not inhibit the growth of Chinese hamster ovary cells or the catalytic activity of DNA topoisomerase II.
Anticancer Drugs. 1998 Jun;9(5):465-71. doi: 10.1097/00001813-199806000-00014.
8
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.催化性DNA拓扑异构酶II抑制剂右丙亚胺(ICRF-187)可诱导人白血病K562细胞分化和凋亡。
Mol Pharmacol. 2001 Mar;59(3):453-61. doi: 10.1124/mol.59.3.453.
9
Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.米替茚地是一种DNA拓扑异构酶II的催化抑制剂,作用于双二氧哌嗪结合位点。
Mol Pharmacol. 1997 Nov;52(5):839-45. doi: 10.1124/mol.52.5.839.
10
The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis.
Anticancer Drugs. 1999 Jan;10(1):47-54. doi: 10.1097/00001813-199901000-00007.

引用本文的文献

1
Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells.一氧化氮抑制人MCF-7乳腺癌细胞中的ATP酶活性并诱导对拓扑异构酶II抑制剂的抗性。
Biochem Biophys Rep. 2017 Apr 20;10:252-259. doi: 10.1016/j.bbrep.2017.04.011. eCollection 2017 Jul.
2
The effect of the catalytic topoisomerase II inhibitor dexrazoxane (ICRF-187) on CC9C10 hybridoma viability and productivity.地塞米松(ICRF-187)作为催化拓扑异构酶 II 抑制剂对 CC9C10 杂交瘤细胞活力和产量的影响。
Cytotechnology. 2001 Oct;37(2):107-17. doi: 10.1023/A:1019910213964.